Analysts' Actions: AAPL NFLX TIF BHI AMGN

TheStreet.com

NEW YORK (TheStreet) -- CHANGE IN RATINGS:

ACCO Brands ACCO upgraded to buy at TheStreet Ratings.

Apple AAPL downgraded at Jefferies to hold from buy, Jefferies said. $500 price target. Demand slowdown and margin pressure.

Albermarle ALB downgraded at JP Morgan from overweight to neutral, JP Morgan said. Valuation call, based on a $67 price target.

Albermarle downgraded at Deutsche from buy to hold, Deutsche Bank said. $70 price target. Company lacks near-term catalysts.

Albemarle downgraded at Citigroup to neutral from buy, Citigroup said. $71 price target. Weaker bromine trends.

Altera ALTR downgraded at William Blair from outperform to market perform, William Blair said. Margins may have peaked as the company is facing product cycle headwinds.

Astoria Financial AF upgraded to buy at TheStreet Ratings.

Bed Bath & Beyond BBBY upgraded at Oppenheimer to outperform from perform, Oppenheimer said. $71 price target. One of best-run companies in retail.

Cubist Pharmaceuticals CBST upgraded at Cantor from sell to hold, Cantor Fitzgerald said. Valuation call, based on a $38 price target.

Dillard's DDS upgraded at Credit Suisse from neutral to outperform, Credit Suisse said. $95 price target. Company is prepared for a shift in retail spending.

Emerson Electric EMR upgraded at Deutsche from hold to buy, Deutsche Bank said. $68 price target. China and other emerging markets can continue to drive growth over the next several quarters.

Energizer ENR downgraded at BMO from outperform to market perform, BMO Capital said. $95 price target. Valuation call, as the stock is up 30% since August.

Flowserve FLS downgraded at Wedbush from outperform to neutral, Wedbush said. $160 price target. Valuation call, as the stock is up 45% over the past year.

Molycorp MCP downgraded at Dahlman from buy to hold, Dahlman Rose said. Company continues to increase its capital spending. $8.13 price target.

Netflix NFLX upgraded at JP Morgan from neutral to overweight, JP Morgan said. $180 price target. Company is carrying a lot of momentum into 2013.

Netflix upgraded at Lazard to buy, Lazard Capital Markets said. $200 price target. Once again appears that the company can deliver strong growth domestically.

Netflix downgraded at Credit Suisse from outperform to neutral, Credit Suisse said. $132 price target. A lot of variability remains in the business model.

Pilgrim's Pride PPC downgraded at B Riley Caris from buy to neutral, B Riley Caris asid. Valuation call, based on a $9 price target.

Ross Stores ROST upgraded at Credit Suissefrom neutral to outperform, Credit Suisse said. $68 price target. Company should continue to benefit from a favorable operating environment.

Sandisk SNDK upgraded at Needham from hold to buy, Needham said. $60 price target. Company is realizing higher margins.

Splunk SPLK rated new outperform at BMO. $39 price target. Company should be able to capture more large enterprise deals.

Symantec SYMC downgraded at Wunderlich from buy to hold, Wunderlich said. $22 price target. Company's strategic turnaround will take time.

Symantec downgraded at Stifel from Buy to Hold, Stifel Nicolaus said. Valuation call, as the company lacks near-term catalysts.

Tiffany TIF downgraded at Canaccord from Buy to Hold, Canaccord Genuity said. $58 price target. Sales momentum continues to decelerate in an uncertain economy.

Veeco Instruments VECO downgraded at UBS to Neutral from Buy, UBS said. $34 price target. China MOCVD demand likely remains lower than expected.

STOCK COMMENTS / EPS CHANGES

Apple AAPL numbers lowered at Oppenheimer. Shares of AAPL now seen reaching $600, Oppenheimer said. Estimates also lowered on disappointing guidance. Outperform rating.

Apple estimates, target reduced at BMO.AAPL estimates were cut through 2014, BMO Capital said. Company lowered its guidance. Outperform rating and new $580 price target.

Apple numbers cut at UBS. Shares of AAPL now seen reaching $600, UBS said. Estimates also lowered on mediocre outlook. Buy rating.

Apple estimates, target cut at Sterne Agee. Shares of AAPL now seen reaching $715, according to Sterne Agee. Estimates also reduced, given the company's new guidance. Buy rating.

Apple numbers cut at Citigroup. Shares of AAPL now seen reaching $500, Citigroup said. Estimates also lowered on weaker iPhone shipments. Neutral rating.

Abbvie ABBV estimates, target boosted at BMO. Shares of ABBV now seen reaching $41, according to BMO Capital. Estimates also upped, given highrer Humira growth. Outperform rating.

Amgen AMGN target raised at Bernstein to $101, Bernstein said. Solid quarter, but lacking near term catalysts. Market Perform rating.

Baker Hughes BHI numbers cut at BMO. Shares of BHI now seen reaching $43, BMO Capital Markets said. Estimates also lowered on outlook which lacks sense of urgency. Market Perform rating.

Baker Hughes target raised at Jefferies to $48, Jefferies said. DCF mechanics. Hold rating.

Colgate-Palmolive CL added to US Focus List at Credit Suisse. Company can deliver industry-leading growth.

F5 Networks FFIV numbers raised at Citigroup. Shares of FFIV now seen reaching $125, Citigroup said. Estimates also increased on potential 2H13 growth reacceleration. Buy rating.

McDonald's MCD estimates, target boosted at Credit Suisse. Shares of MCD now seen reaching $102, according to Credit Suisse. Estimates also upped, as the company appears to be gaining market share in the U.S. Outperform rating

McDonald's numbers raised at BMO. Shares of MCD now seen reaching $98, BMO Capital Markets said. Estimates also increased on solid quarter. Market Perform rating.

Newmont Mining NEM numbers lowered at Jefferies. Shares of NEM now seen reaching $44, Jefferies said. Estimates also lowered on long- term guidance has been overoptimistic. Hold rating.

Netflix NFLX estimates, target increased at BMO. NFLX estimates were raised through 2014, BMO Capital said. Company is seeing higher subscriber growth. Market Perform rating and new $135 price target.

Netflix numbers raised at Citigroup. Shares of NFLX now seen reaching $160, Citigroup said. Estimates also increased on clean beat and raise 4Q results. Buy rating.

Rock-Tenn RKT target raised at Jefferies to $93, Jefferies said. Improved execution. Buy rating.

Sandisk SNDK estimates, target raised at Credit Suisse. Shares of SNDK now seen reaching $55, according to Credit Suisse. Estimates also increased, as the company is realizing higher margins. Outperform rating.

Stryker SYK numbers raised at BMO. Shares of SYK now seen reaching $65, BMO Capital Markets said. Estimates also increased folliwng a good recon quarter. Market Perform rating.

Stryker target raised at Jefferies. Shares of SYK now seen reaching $66, Jefferies said. Encouraging signs in the quarter. Hold rating.

Symantec SYMC numbers raised at Oppenheimer. Shares of SYMC now seen reaching $25, Oppenheimer said. Estimates also raised on second straight strong quarter. Outperform rating.

United Technologies UTX numbers raised at Credit Suisse. Shares of UTX now seen reaching $94, according to Credit Suisse. Estimates also increased, as the company is seeing higher Aero systems growth. Outperform rating.

United Technologies target raised at Jefferies to $96, Jefferies said. BRICs are delivering. Buy rating.

Varian Medical Systems VAR numbers raised at Jefferies. Shares of VAR now seen reaching $80, Jefferies said. Estimates also raised on leadership position within the market. Buy rating.

Western Digital WDC numbers upped at BofA/Merrill. WDC estimates were boosted through 2014, Bank of America/Merrill Lynch said. Company boosted its guidance. Neutral rating and new $52 price target.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.

View Comments (1)